Javascript must be enabled to continue!
Data from Akt Phosphorylation of Merlin Enhances Its Binding to Phosphatidylinositols and Inhibits the Tumor-Suppressive Activities of Merlin
View through CrossRef
<div>Abstract<p>The NF2 tumor suppressor gene encodes an intracellular membrane-associated protein, called merlin, which belongs to the band 4.1 family of cytoskeleton-associated proteins that link cell surface glycoproteins to the actin cytoskeleton. Merlin suppresses phosphatidylinositol 3-kinase (PI3K)/Akt signaling by directly binding and inhibiting the stimulatory activity of PIKE-L on PI3K. Akt feeds back and phosphorylates merlin and provokes its polyubiquitination and degradation. Here, we show that Akt phosphorylation and PI(3,4,5)P<sub>3</sub> binding mediate the tumor-suppressive activity of merlin. The extreme NH<sub>2</sub> terminus of merlin directly interacts with phosphatidylinositols, for which the unfolded conformation is required. Moreover, Akt phosphorylation enhances merlin binding affinity to phosphatidylinositols and inhibits its proapoptotic actions. Furthermore, Akt phosphorylation and phosphatidylinositols increase merlin binding to CD44. Epidermal growth factor treatment and Akt phosphorylation provoke merlin to aggregate in the ruffled plasma membrane and promote cell migration. Thus, these results suggest that PI3K signaling regulates the tumor-suppressive activity of merlin via both Akt phosphorylation and phosphatidylinositol lipids binding to merlin. [Cancer Res 2009;69(9):4043–51]</p></div>
American Association for Cancer Research (AACR)
Title: Data from Akt Phosphorylation of Merlin Enhances Its Binding to Phosphatidylinositols and Inhibits the Tumor-Suppressive Activities of Merlin
Description:
<div>Abstract<p>The NF2 tumor suppressor gene encodes an intracellular membrane-associated protein, called merlin, which belongs to the band 4.
1 family of cytoskeleton-associated proteins that link cell surface glycoproteins to the actin cytoskeleton.
Merlin suppresses phosphatidylinositol 3-kinase (PI3K)/Akt signaling by directly binding and inhibiting the stimulatory activity of PIKE-L on PI3K.
Akt feeds back and phosphorylates merlin and provokes its polyubiquitination and degradation.
Here, we show that Akt phosphorylation and PI(3,4,5)P<sub>3</sub> binding mediate the tumor-suppressive activity of merlin.
The extreme NH<sub>2</sub> terminus of merlin directly interacts with phosphatidylinositols, for which the unfolded conformation is required.
Moreover, Akt phosphorylation enhances merlin binding affinity to phosphatidylinositols and inhibits its proapoptotic actions.
Furthermore, Akt phosphorylation and phosphatidylinositols increase merlin binding to CD44.
Epidermal growth factor treatment and Akt phosphorylation provoke merlin to aggregate in the ruffled plasma membrane and promote cell migration.
Thus, these results suggest that PI3K signaling regulates the tumor-suppressive activity of merlin via both Akt phosphorylation and phosphatidylinositol lipids binding to merlin.
[Cancer Res 2009;69(9):4043–51]</p></div>.
Related Results
Data from Akt Phosphorylation of Merlin Enhances Its Binding to Phosphatidylinositols and Inhibits the Tumor-Suppressive Activities of Merlin
Data from Akt Phosphorylation of Merlin Enhances Its Binding to Phosphatidylinositols and Inhibits the Tumor-Suppressive Activities of Merlin
<div>Abstract<p>The NF2 tumor suppressor gene encodes an intracellular membrane-associated protein, called merlin, which belongs to the band 4.1 family of cytoskeleton-...
Abstract 1430: CaMKK2 regulates EGF-dependent activation of oncogenic Akt in ovarian cancer cells
Abstract 1430: CaMKK2 regulates EGF-dependent activation of oncogenic Akt in ovarian cancer cells
Abstract
Background-The canonical PI3K/Akt pathway is hyperactive in a variety of cancers including ovarian cancer (OVCa). Using baculovirus-expressed, FPLC-purified...
Supplementary Figure 1 from Akt Phosphorylation of Merlin Enhances Its Binding to Phosphatidylinositols and Inhibits the Tumor-Suppressive Activities of Merlin
Supplementary Figure 1 from Akt Phosphorylation of Merlin Enhances Its Binding to Phosphatidylinositols and Inhibits the Tumor-Suppressive Activities of Merlin
Supplementary Figure 1 from Akt Phosphorylation of Merlin Enhances Its Binding to Phosphatidylinositols and Inhibits the Tumor-Suppressive Activities of Merlin...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Patterns and Prognostic Impact of PI3K-AKT Pathway Activation, Regulation and Downstream Activity in AML Using Reverse Phase Proteins Arrays (RPPA).
Patterns and Prognostic Impact of PI3K-AKT Pathway Activation, Regulation and Downstream Activity in AML Using Reverse Phase Proteins Arrays (RPPA).
Abstract
Functional activation of the PI3K/AKT signaling pathway provides survival signals to leukemic cells and pathway blockade may facilitate cell death. We have ...
Abstract 3595: Abrogation of Akt signaling by Isobavachalcone contributes to its antiproliferative effect towards human cancer cells
Abstract 3595: Abrogation of Akt signaling by Isobavachalcone contributes to its antiproliferative effect towards human cancer cells
Abstract
The Akt (Protein kinase B, PKB) kinase is a key intermediate of many cellular processes and plays a critical role in cancer promotion and progression. Akt s...
Abstract 1133: Glucose deprivation-induced intracellular reactive oxygen species activates the PI3K-AKT axis
Abstract 1133: Glucose deprivation-induced intracellular reactive oxygen species activates the PI3K-AKT axis
Abstract
Glucose is the most efficient energy source and various cancer cells depend on glycolysis for their energy production. On the other hand, tumor microenviron...
Abstract 3659: The AKT inhibitor MK-2206 promotes apoptosis in acute myeloid leukemia cells
Abstract 3659: The AKT inhibitor MK-2206 promotes apoptosis in acute myeloid leukemia cells
Abstract
The need for improved therapies for acute myeloid leukemia (AML) is urgent as the disease is still highly fatal. Protein Kinase B (AKT) activation has been ...

